-
F287817-50mgPotent group I PAK inhibitor.
-
F287817-5mgPotent group I PAK inhibitor.
-
F610403-25mgfrescolat MGA.
-
-
-
-
F610405-25mgfrovatriptan.
-
F610405-5mgfrovatriptan.
-
-
-
F288677-10mgProduct descriptionFTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on
-
F288677-25mgProduct descriptionFTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on